Molecular targeted enhanced ultrasound imaging of flkl reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model

Keyphrases

• Mouse Prostate 100%
• Ultrasound Imaging 100%
• Molecular Targets 100%
• Genetically Engineered Mice 100%
• Prostate Cancer Model 100%
• Flk-1 100%
• Enhanced Ultrasound 100%
• Prostate Cancer 30%
• Ultrasound 30%
• Tumor 20%
• Prostate 20%
• Genetically Engineered Mouse Models 20%
• Imaging Marker 20%
• Targeted Ultrasound 20%
• Molecular Imaging 10%
• Early Treatment 10%
• Tumor Size 10%
• Tumor Cells 10%
• Tumor Growth 10%
• Tumor Progression 10%
• Angiogenesis 10%
• Group by 10%
• Small Tumor 10%
• Tumor Metastasis 10%
• Histological Analysis 10%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 10%
• Urethra 10%
• New Tumor 10%
• Vascular Function 10%
• Pelvic Lymph Nodes 10%
• Molecular Signaling 10%
• Immuno 10%
• Microimaging 10%
• Molecular Imaging Techniques 10%
• Prognosis Marker 10%
• Targeted Imaging 10%
• 3D Ultrasound 10%
• Imaging Tools 10%
• Correlation Study 10%
• Switch-off 10%
• Tumor Blood Vessels 10%
• Small Media 10%
• Angiogenesis Factor 10%
• Gross Pathology 10%
• Histochemical Analysis 10%
• Boundary Region 10%
• Microbubble-enhanced Ultrasound 10%
• B-mode Image 10%
• Pathology Analysis 10%
• Longitudinal Observation 10%
• Targeted Microbubbles 10%
• Molecular Prognosis 10%
• Molecular Diagnostic Marker 10%
• Molecular Targeted Imaging 10%
• Accumulation Stage 10%

Medicine and Dentistry

• Prostate Cancer 100%
• Cancer Model 100%
• Ultrasonography 100%
• Neoplasm 50%
• Tumor Progression 50%
• Molecular Imaging 50%
• Tumor 50%
• Diseases 25%
• Imaging Technique 25%
• Malignant Neoplasm 25%
• Pelvis 25%
• Metastatic Carcinoma 25%
• Immunoglobulin 25%
• Tumor Cell 25%
• Histochemistry 25%
• Vascularity 25%
• Angiogenesis 25%
• Molecular Diagnosis 25%
• Angiogenic Factor 25%
• Vascular Tissue Neoplasm 25%
• Vasculotropin Receptor 2 25%
• Gross Pathology 25%

Biochemistry, Genetics and Molecular Biology

• Cancer Model 100%
• Genetically Engineered Mouse Strain 100%
• Mouse Model 66%
• Angiogenesis 66%
• Tumor Volume 33%
• Intravenous Immunoglobulin 33%
• Tumor Progression 33%
• Microbubble 33%
• Kinase Insert Domain Receptor 33%
• Vascularization 33%